Medicine
Acute Kidney Injury in Rhabdomyolysis: Pathophysiology and Treatment
Quick fact
In rhabdomyolysis, myoglobin entering the bloodstream can precipitate in kidney tubules and cause acute tubular necrosis; aggressive IV fluids can raise urine output to flush the myoglobin out, reducing the risk of permanent kidney damage.
Why this is interesting
Crushed muscle may not kill you directly—but the chemicals it releases into your blood can shut down your kidneys. How does a leg injury become a kidney emergency?
Read the full explanation
Understanding Acute Kidney Injury in Rhabdomyolysis: Pathophysiology and Treatment
Imagine your muscle cells as tiny water balloons filled with a red protein called myoglobin—the molecule that gives muscle its red color. When muscle is severely damaged (from crush injury, extreme exercise, certain drugs, or prolonged immobility), those balloons burst, spilling their contents into your bloodstream. Your kidneys, which filter your blood, suddenly have to deal with a flood of myoglobin. The nephrons—the functional units of the kidney—make urine by filtering blood and then reabsorbing water and solutes. But myoglobin is bulky and can clump together, especially in the concentrated, acidic environment of the tubules. These clumps can physically plug the tiny tubes, like a recycling plant being jammed with too many oversize cardboard boxes. At the same time, myoglobin itself is toxic to the tubular cells, and it causes the kidney's blood vessels to constrict, reducing blood flow and oxygen supply, starving the tubules. This triple insult—clogging, toxicity, and ischemia—leads to acute kidney injury (AKI). The result is a rapid decline in the kidney's ability to filter waste, leading to a buildup of waste products and dangerously high potassium levels. The good news is that AKI from rhabdomyolysis is often preventable if caught early: by giving lots of IV fluids, we can 'flush' the myoglobin out before it gets stuck.
A deeper explanation
The pathophysiology of rhabdomyolysis-induced AKI involves three synergistic mechanisms: renal vasoconstriction, tubular obstruction, and direct tubular toxicity. Muscle damage releases myoglobin, which is filtered by the glomerulus but can be reabsorbed by proximal tubule cells. Inside these cells, myoglobin dissociates into ferrihemate (a heme-containing breakdown product) which generates free radicals, causing oxidative stress and cellular injury. Furthermore, myoglobin binds to nitric oxide, a vasodilator, leading to renal afferent arteriolar vasoconstriction and decreased glomerular filtration. In the distal tubules, myoglobin interacts with Tamm-Horsfall glycoprotein to form casts, which obstruct urine flow and increase intratubular pressure, further reducing filtration. Additionally, damaged muscle cells release massive amounts of potassium, phosphate, and uric acid, compounding the risk of arrhythmias and crystal nephropathy. Treatment is therefore multifactorial: aggressive isotonic fluid resuscitation (often starting with 1-2 liters per hour) to maintain high urine output, which dilutes the myoglobin and flushes it before casts form; sodium bicarbonate may be used to alkalinize urine, which reduces myoglobin's tendency to precipitate and minimizes tubular toxicity; mannitol can promote osmotic diuresis, although its benefit is debated. Meanwhile, electrolyte abnormalities must be corrected, especially hyperkalemia, which is a leading cause of early death. Timely recognition and fluid therapy can dramatically reduce the incidence of AKI and the need for dialysis, underscoring the principle that in rhabdomyolysis, 'an ounce of prevention is worth a pound of cure.'